Trial Outcomes & Findings for Trial to Test if Antibiotic Ointments & Cream Will Sting After Application on a Minor Wound After Tape Stripping Injury (NCT NCT02320695)

NCT ID: NCT02320695

Last Updated: 2016-01-05

Results Overview

The stinging sensation was assessed by the subject using the following scale: 0 = no stinging sensation, 1 = mild stinging sensation, 2 = moderate stinging sensation, and 3 = severe stinging sensation at post-tape stripping and immediately after product application. Change from post-tape striping was calculated as the subject assessment of stinging sensation immediately after investigational product application minus the subject assessment of stinging sensation at post-tape stripping.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

60 participants

Primary outcome timeframe

Post-tape stripping to immediately after investigational product application

Results posted on

2016-01-05

Participant Flow

Participant milestones

Participant milestones
Measure
OVERALL
Subjects were assigned to each of the following interventions: Saline, Isopropyl Alcohol, Neosporin Plus Pain Relieving Cream, Neosporin Complete First Aid Antibiotic/Pain Relieving Ointment, Neosporin Original Ointment, Neosporin Plus Pain Relief Ointment. The sequence in which participants received the intervention was randomized.
Overall Study
STARTED
60
Overall Study
Saline
60
Overall Study
Alcohol
60
Overall Study
Pain Relieving Cream
59
Overall Study
Antibiotic/Pain Relieving Ointment
60
Overall Study
Original Ointment
60
Overall Study
Pain Relief Ointment
60
Overall Study
COMPLETED
60
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Trial to Test if Antibiotic Ointments & Cream Will Sting After Application on a Minor Wound After Tape Stripping Injury

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
OVERALL
n=60 Participants
This includes all 60 randomized subjects. Subjects were assigned to each of the following interventions: Saline, Isopropyl Alcohol, Neosporin Plus Pain Relieving Cream, Neosporin Complete First Aid Antibiotic/Pain Relieving Ointment, Neosporin Original Ointment, Neosporin Plus Pain Relief Ointment. The sequence in which participants received the intervention was randomized.
Age, Continuous
51.2 years
STANDARD_DEVIATION 13.24 • n=39 Participants
Sex: Female, Male
Female
50 Participants
n=39 Participants
Sex: Female, Male
Male
10 Participants
n=39 Participants
Region of Enrollment
United States
60 participants
n=39 Participants

PRIMARY outcome

Timeframe: Post-tape stripping to immediately after investigational product application

Population: Analysis was based on all randomized subjects who initiated the tape-stripping procedures and perceived sting sensation immediately after the application of alcohol.

The stinging sensation was assessed by the subject using the following scale: 0 = no stinging sensation, 1 = mild stinging sensation, 2 = moderate stinging sensation, and 3 = severe stinging sensation at post-tape stripping and immediately after product application. Change from post-tape striping was calculated as the subject assessment of stinging sensation immediately after investigational product application minus the subject assessment of stinging sensation at post-tape stripping.

Outcome measures

Outcome measures
Measure
Saline
n=34 Participants
0.9% Sodium Chloride Saline Solution (0.3 cc)
Isopropyl Alcohol
n=34 Participants
70% Isopropyl Alcohol (0.3 cc)
Pain Relieving Cream
n=33 Participants
Neosporin® Plus Pain Relieving Cream formula with pH balance technology (0.3 cc)
Antibiotic/Pain Relieving Ointment
n=34 Participants
Neosporin® Complete First Aid Antibiotic/Pain Relieving Ointment (0.3 cc)
Original Ointment
n=34 Participants
Neosporin® Original Ointment (0.3 cc)
Pain Relief Ointment
n=34 Participants
Neosporin® Plus Pain relief Ointment (0.3 cc)
Mean Change From Post-Tape Stripping in Subject Assessment of Stinging Sensation Immediately After Investigational Product Application
-0.29 units on a scale
Standard Deviation 0.84
0.82 units on a scale
Standard Deviation 0.94
-0.55 units on a scale
Standard Deviation 0.67
-0.65 units on a scale
Standard Deviation 0.73
-0.47 units on a scale
Standard Deviation 0.61
-0.71 units on a scale
Standard Deviation 0.58

PRIMARY outcome

Timeframe: Post-tape stripping to one minute after investigational product application

Population: Analysis was based on all randomized subjects who initiated the tape-stripping procedures and perceived sting sensation immediately after the application of alcohol.

The stinging sensation was assessed by the subject using the following scale: 0 = no stinging sensation, 1 = mild stinging sensation, 2 = moderate stinging sensation, and 3 = severe stinging sensation at post-tape stripping and one minute after investigational product application. Change from post-tape striping was calculated as the subject assessment of stinging sensation at one minute after investigational product application minus the subject assessment of stinging sensation at post-tape stripping.

Outcome measures

Outcome measures
Measure
Saline
n=34 Participants
0.9% Sodium Chloride Saline Solution (0.3 cc)
Isopropyl Alcohol
n=34 Participants
70% Isopropyl Alcohol (0.3 cc)
Pain Relieving Cream
n=33 Participants
Neosporin® Plus Pain Relieving Cream formula with pH balance technology (0.3 cc)
Antibiotic/Pain Relieving Ointment
n=34 Participants
Neosporin® Complete First Aid Antibiotic/Pain Relieving Ointment (0.3 cc)
Original Ointment
n=34 Participants
Neosporin® Original Ointment (0.3 cc)
Pain Relief Ointment
n=34 Participants
Neosporin® Plus Pain relief Ointment (0.3 cc)
Mean Change From Post-Tape Stripping in Subject Assessment of Stinging Sensation One Minute After Investigational Product Application
-0.24 units on a scale
Standard Deviation 0.92
-0.35 units on a scale
Standard Deviation 0.73
-0.67 units on a scale
Standard Deviation 0.65
-0.47 units on a scale
Standard Deviation 0.86
-0.50 units on a scale
Standard Deviation 0.56
-0.68 units on a scale
Standard Deviation 0.64

SECONDARY outcome

Timeframe: Day 1

Population: The Intent-to-Treat (ITT) analysis population included all randomized subjects who had initiated the tape-stripping procedures.

The clinician evaluated the wound using the following scale: 0 = minimal severity, 10 = maximal severity.

Outcome measures

Outcome measures
Measure
Saline
n=60 Participants
0.9% Sodium Chloride Saline Solution (0.3 cc)
Isopropyl Alcohol
n=60 Participants
70% Isopropyl Alcohol (0.3 cc)
Pain Relieving Cream
n=59 Participants
Neosporin® Plus Pain Relieving Cream formula with pH balance technology (0.3 cc)
Antibiotic/Pain Relieving Ointment
n=60 Participants
Neosporin® Complete First Aid Antibiotic/Pain Relieving Ointment (0.3 cc)
Original Ointment
n=60 Participants
Neosporin® Original Ointment (0.3 cc)
Pain Relief Ointment
n=60 Participants
Neosporin® Plus Pain relief Ointment (0.3 cc)
Mean Clinician Rating of Overall Wound Condition on Day 1
2.42 units on a scale
Standard Deviation 1.18
2.10 units on a scale
Standard Deviation 1.02
2.22 units on a scale
Standard Deviation 1.00
2.50 units on a scale
Standard Deviation 1.13
2.32 units on a scale
Standard Deviation 1.23
2.15 units on a scale
Standard Deviation 0.97

SECONDARY outcome

Timeframe: Day 8

Population: The Intent-to-Treat (ITT) analysis population included all randomized subjects who had initiated the tape-stripping procedures.

The clinician evaluated the wound using the following scale: 0 = minimal severity, 10 = maximal severity.

Outcome measures

Outcome measures
Measure
Saline
n=60 Participants
0.9% Sodium Chloride Saline Solution (0.3 cc)
Isopropyl Alcohol
n=60 Participants
70% Isopropyl Alcohol (0.3 cc)
Pain Relieving Cream
n=59 Participants
Neosporin® Plus Pain Relieving Cream formula with pH balance technology (0.3 cc)
Antibiotic/Pain Relieving Ointment
n=60 Participants
Neosporin® Complete First Aid Antibiotic/Pain Relieving Ointment (0.3 cc)
Original Ointment
n=60 Participants
Neosporin® Original Ointment (0.3 cc)
Pain Relief Ointment
n=60 Participants
Neosporin® Plus Pain relief Ointment (0.3 cc)
Mean Clinician Rating of Overall Wound Condition on Day 8
1.43 units on a scale
Standard Deviation 0.85
1.35 units on a scale
Standard Deviation 0.68
1.37 units on a scale
Standard Deviation 0.83
1.35 units on a scale
Standard Deviation 0.73
1.47 units on a scale
Standard Deviation 0.89
1.38 units on a scale
Standard Deviation 0.76

Adverse Events

OVERALL

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Christopher Nunez, PhD

Johnson & Johnson Consumer and Personal Products Worldwide

Phone: 973-385-7984

Results disclosure agreements

  • Principal investigator is a sponsor employee Principal investigator agreed not to publish the study results without prior sponsor approval.
  • Publication restrictions are in place

Restriction type: OTHER